| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157952 | American Journal of Kidney Diseases | 2012 | 7 Pages |
Abstract
Use of ACE inhibitors/ARBs during CAG has a possible influence to increase the incidence of contrast-induced AKI. Further randomized clinical trials are warranted to confirm the effect of ACE-inhibitor/ARB therapy on the development of contrast-induced AKI.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Min Young MD, Han MD, PhD, Woong Chol MD, PhD, Ae Jin MD, Hyeonsu MD, Jae Hyun MD, Hyun Hee MD, Wookyung MD, PhD, Ji Yong MD, PhD,